neuralink-s-speech-restoring-device-set-for-clinical-trial-111

Neuralink’s speech-restoring device set for clinical trial

NotebookLM just went mobile, giving you a smarter way to learn, organize, and listen. Anytime, anywhere.

By
Edison
•

Oct 1, 2025

Copy link
Share on X
Share on LinkedIn
Share on Instagram
Share via Facebook
I

t’s the stuff of science fiction, but this isn’t “Star Trek,” and it’s no longer fiction as Elon Musk’s Nearalink gears up to test another brain chip device, this time for those who have lost their ability to speak. 

Neuralink will start a clinical trial of its newest device designed to restore speech as early as next month, according to a new report.


In May, Elon Musk’s brain implant company received FDA Breakthrough Designation for its implanted brain-computer interface technology that the company said will let those with speech disorders communicate again by recording and decoding brain signals to turn thought into speech or text. 

Neuralink’s speech-restoring device set for clinical

A link to join Neuralink’s patient registry to be part of the clinical trial is still live on the company’s website. 

During a lecture at the Korea Foundation for Advanced Studies in Seoul last week, Neuralink’s president and COO DJ Seo discussed the project as part of his presentation, Bloomberg reported. Seo said the device could translate imagined speech into actual words.

It’s the stuff of science fiction, but this isn’t “Star Trek,” and it’s no longer fiction as Elon Musk’s Nearalink gears up to test another brain chip device, this time for those who have lost their ability to speak. 

Neuralink will start a clinical trial of its newest device designed to restore speech as early as next month, according to a new report.

In May, Elon Musk’s brain implant company received FDA Breakthrough Designation for its implanted brain-computer interface technology that the company said will let those with speech disorders communicate again by recording and decoding brain signals to turn thought into speech or text. 

A link to join Neuralink’s patient registry to be part of the clinical trial is still live on the company’s website. 

During a lecture at the Korea Foundation for Advanced Studies in Seoul last week, Neuralink’s president and COO DJ Seo discussed the project as part of his presentation, Bloomberg reported. Seo said the device could translate imagined speech into actual words.